A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

The first report to compare what pharmaceutical companies are doing to bring antimicrobial resistance under control. By highlighting where good ideas are being implemented, it encourages their wider uptake.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Overall ranking Vacancies Funding Methodology Key Finding

In the media

Read how the global media covers how pharmaceutical companies respond to market trends and global health issues using the Foundation's research, and translates the complexity of access to medicine for the public.

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

20 Nov 2018

Big pharma leaves big gaps: drugmakers urged to do more for poor

Writing for Reuters, Ben Hirschler covers the 2018 Access to Medicine Index: "Many of the world’s top drugmakers are not doing enough to provide medic...

20 Nov 2018

Big pharma' urged to develop treatments for global health

Anne Gulland reports on how the 2018 Index found that just five firms — GSK, Johnson & Johnson, Sanofi, Merck and Novartis — are cond...

20 Nov 2018

Farmaceuten geven maar paar ziekten in arme landen topprioriteit

NOS reports on the 2018 Index highlighting the five companies that are conducting R&D for diseases listed as global priorities.  The article als...

20 Nov 2018

Pharmafirmen sollten wetteifern, wer mehr Gutes tut

Jakob Simmank of Die Zeit interviews Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, on the latest results of the Access to...

20 Nov 2018

Ranking Big Pharma's performance on access to medicines

Sarah Wheaten of Politico interviews Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, and Danny Edwards, Research Progr...

20 Nov 2018

One trend in access to medicines may be cause for concern

Catherine Cheney of Devex reports on the results of the 2018 Access to Medicine Index. She highlights the handful of companies carrying out the most u...

20 Nov 2018

Cancer Breakthroughs Are Set to Elude World's Poor, Study Says

Writing for Bloomberg, Naomi Kresge covers the results of the latest Access to Medicine Index: "Giant drugmakers pouring resources into new...

20 Nov 2018

Big pharma failing to develop urgent drugs for poorest countries

Julia Kollewe of the Guardian covers the latest Access to Medicine Index: "most firms focus on infectious diseases such as HIV/Aids, malaria and tuber...

20 Nov 2018

Only a few drug makers are actively targeting medicines needed in poor countries

In this article, Ed Silverman of STAT news covers the results of the 2018 Access to Medicine Index: "A new report finds five large drug makers ar...

20 Nov 2018

GSK tops ranking for making drugs available to poor people

Rebecca Coombes of the British Medical Journal covers the Foundation's latest Access to Medicine Index. The article highlights the five companies carr...

20 Nov 2018

Research burden carried by a handful of drug companies, says report

Jyothi Datta of the Hindu Business Line reports on the results of the 2018 Access to Medicine Index. The article focuses on the handful companies carr...

20 Nov 2018

Only a handful of pharma cos are developing the much needed medicines for the poor : ATMI 2018

The Economic Times of India covers the Foundation's latest Access to Medicine Index. The article focuses on the the five companies that are carrying o...

20 Nov 2018

Industry invests in supply chain strategies for low-income countries

Ben Hargreaves of in-Pharma Technologist reports on the 2018 Access to Medicine Index. The article focuses on three areas for ensuring the continuous...

20 Nov 2018

Pharmakonzerne vernachlässigen Medizin für die Ärmsten

Anja Ettel of Die Welt covers the latest results of the Access to Medicine Index. The article focuses on the handful of companies carrying out the maj...

20 Nov 2018

Listen (Dutch): Nieuws & Co.

Marijn Verhoef of the Access to Medicine Foundation joins Lara Rense's Nieuws & Co. drive time show to delve into the results of the 2018 Access to Me...

20 Nov 2018

Handvol bedrijven zet in op geneesmiddelen voor arme landen

Isabelle Vanhoutte of Belgium's De Staandard reports on the 2018 Access to Medicine Index. The article leads with the five companies carrying out the...

Got a question?

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.